| Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients | A Double-Blind, Double-Dummy, Placebo-Controlled, Dose Ranging Study of 7.5, 15, and 30 mg of Sublingual Lobeline in Adult ADHD Patients | NCT00664703 |
| Ph1 Lobeline Interaction Study - 1 | Double-Blind, Placebo-Controlled, Cross-Over Assessment of Intravenous Methamphetamine and Sublingual Lobeline Interactions | NCT00439504 |
| To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 | Safety and Tolerability Study of Sublingual Lobeline | NCT00100074 |
| Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 | Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline | NCT00519259 |
